Else Nutrition

AEye Reports Third Quarter 2022 Results

10 November 2022

Third quarter revenue in line with expectations Product launch, new markets expansion, and continued momentum with existing partners provide foundation for growth

AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high performance lidar solutions, today announced its results for the third quarter, ended September 30, 2022.

“As planned, today we are excited to launch our 4Sight™ line of products which we believe to be built on the industry’s premier high performance adaptive lidar platform. The reaction we are getting from users who require high performance capabilities like autonomous hub-to-hub trucking, true high-speed highway autopilot, and other high-impact industrial, aerospace, and defense applications is incredibly encouraging. We believe the 4Sight platform is groundbreaking and will accelerate the adoption of lidar across diverse markets. The 4Sight platform differs from many other ‘point’ lidar solutions in that it is natively architected to integrate with other sensors and across networks to not only deliver optimal pre-perception data, but also help users customize how, when, and where they process critical information to make autonomous decisions,” said Luis Dussan, founder and chief technology officer of AEye.

“Today, we also are announcing that we have broken ground on our high-volume manufacturing line at Sanmina’s future plant in Thailand. The commitment from our partners to build out high-volume and low-cost manufacturing capabilities represents an important accomplishment and is a key component in our differentiated business model to drive market and customer expansion as the lidar industry scales. We believe AEye is the only lidar supplier to have two manufacturing partners, Sanmina and Continental, in a capital-light business model,” said Blair LaCorte, chief executive officer of AEye.

Q3 2022 Financials

  • Revenue of $0.8 million in the third quarter of 2022.
  • GAAP net loss was $(23.6) million in the third quarter of 2022, or $(0.15) per share based on 159.3 million weighted average common shares outstanding.
  • Non-GAAP net loss was $(17.0) million in the third quarter of 2022, or $(0.11) per share based on 159.3 million weighted average common shares outstanding.
  • Cash, cash equivalents, and marketable securities were $112.2 million as of September 30, 2022. This excludes up to $122 million in available liquidity from our Common Stock Purchase Agreement with Tumim Stone Capital LLC.

Conference Call and Webcast Details

AEye management will hold a conference call today, November 10, 2022, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these results. AEye CEO Blair LaCorte and CFO Bob Brown will host the call, followed by a question-and-answer session.

The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.

The call is also accessible via telephone through the following details:

Dial in Information:

  • Participant Toll-Free Dial-In Number: 844-763-8274
  • Participant International Dial-In Number: 412-717-9224

About AEye

AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, logistics and off-highway applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most; delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Japan, Korea, and the United States.

Non-GAAP Financial Measures

The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in the United States. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. AEye considers these non-GAAP financial measures to be important because they provide additional insight into the Company’s on-going performance. The Company provides this information to investors for a more consistent basis of comparison and to help investors evaluate the results of the Company’s on-going operations, and to help enable more meaningful period-to-period comparison. Non-GAAP financial measures are presented only as supplemental information for the purpose of understanding the Company’s operating results. The non-GAAP financial measures should not be considered a substitute for financial information presented in accordance with GAAP.

This presentation includes non-GAAP financial measures, including:

  • Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to registrations on Form S-1/S-3, plus stock issuance costs, less change in fair value of embedded derivative and warrant liabilities, plus debt issuance costs, less the gain on PPP loan forgiveness; and
  • Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other, plus provision for income tax expense.

Forward-Looking Statements

Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about AEye’s products, the Company’s progress in commercialization and manufacturing, the potential of new market segments, and the Company’s expected future growth, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of AEye. Many factors could cause actual future events to differ from the forward-looking statements in this press release, including but not limited to: (i) the risks that AEye’s product launch, new markets expansion, or continued momentum with existing partners may not provide a foundation for growth to the extent anticipated or in the timeframe contemplated, or at all; (ii) the risks that AEye’s 4Sight line of products may not be perceived in the marketplace as the industry’s premier high performance adaptive lidar platform to the extent anticipated, or at all; (iii) the risks that AEye’s high performance lidar may not be sufficiently different from other “point” lidar solutions to permit the AEye products to have a competitive advantage in the marketplace or be compelling to customers to the extent anticipated, or at all; (iv) the risks that the 4Sight platform is not perceived by the marketplace as groundbreaking to the extent anticipated, or at all; (v) the risks that the 4Sight platform, by itself, or in conjunction with other lidar products on the market, does not accelerate the adoption of lidar across any markets, to the extent anticipated, or at all; (vi) the risks that AEye’s 4Sight platform may not integrate with other sensors or across networks to deliver optimal pre-perception data, or help users customize how, when, and where they process critical information to make autonomous decisions to the extent anticipated, or at all; (vii) the risks that the reactions AEye has received from users, including those who require high performance capabilities, like autonomous hub-to-hub trucking, true high-speed highway autopilot, and other high-impact industrial, aerospace, and defense applications, will not translate into product orders as anticipated, or at all; (viii) the risks that the low-cost high-volume manufacturing line at Sanmina’s future plant in Thailand will be operational in the timeframe contemplated, or at all, and, that once operational, will achieve the cost structure or volumes anticipated; (ix) the risks that AEye’s competitors adopt a capital-light business model, or such competitors commence operations with additional manufacturing partners; (x) the risks that our partners will not build out the high-volume and low-cost manufacturing capabilities as anticipated, or at all, or in the timeframe anticipated; (xi) the risks that the high-volume and low-cost manufacturing capabilities fail to drive market and customer expansion as anticipated, or at all; (xii) the risks that AEye may not be able to successfully navigate either or both of the supply chain disruptions it faces or the inflationary challenges that currently exist and which may continue for a time period that is longer than anticipated, or is more severe than contemplated; (xiii) the risks that AEye’s innovative, capital-light, and high margin business model will not enable AEye to achieve future growth to the extent anticipated or in the timeframe contemplated, or at all; (xiv) the risks that the traction gained by AEye to date will translate into future growth, revenue, or profitability to the extent anticipated or in the timeframe contemplated, or at all; (xv) the risks that AEye will be unable to strengthen its competitive position or deliver on its key objectives in 2022 due to supply chain disruptions, economic uncertainties, or otherwise; (xvi) the risks that competing technologies will improve over time to become operationally equivalent or more cost-effective, or both, as compared to AEye’s product offering; (xvii) the risks that competitors may introduce products with similar capabilities to AEye’s products and such competitive products are able to take some or all of the market share away from AEye; (xviii) the risks that AEye’s products will not meet the diverse range of performance and functional requirements of AEye’s target markets and customers; (xix) the risks that AEye’s products will not function as anticipated by AEye or by AEye’s target markets and customers; (xx) the risks that the size of the total available market for the use of lidar will be smaller than predicted or take longer to come to fruition than predicted; (xxi) the risk that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xxii) changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xxiii) the risks that AEye may not continue to execute against its business plan to the extent anticipated, or at all; (xxiv) the risks that AEye may be unable to deliver on the promise of SAE Level 4 autonomous driving, hub-to-hub autonomous trucking, or highway autopilot, to the extent anticipated, or at all; (xxv) the risks that lidar adoption occurs slower than anticipated or fails to occur at all; (xxvi) the risks that AEye’s products will not function as anticipated by AEye, or by target markets and customers; (xxvii) the risks that AEye may not be in a position to adequately or timely address either the near or long-term opportunities that may or may not exist in the evolving autonomous transportation industry; (xxviii) the risks that laws and regulations are adopted impacting the use of lidar that AEye is unable to comply with, in whole or in part; (xxix) the risks associated with changes in competitive and regulated industries in which AEye operates, variations in operating performance across competitors, and changes in laws and regulations affecting AEye’s business; (xxx) the risks that AEye is unable to adequately implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; and (xxxi) the risks of downturns and a changing regulatory landscape in the highly competitive and evolving industry in which AEye operates. These risks and uncertainties may be amplified by the COVID-19 pandemic, including the Delta and Omicron variants, as well as future variants and subvariants, which has caused significant economic uncertainty. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Quarterly Report on Form 10-Q that AEye has most recently filed with the U.S. Securities and Exchange Commission, or the SEC, and other documents filed by us or that will be filed by us from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made.

Readers are cautioned not to put undue reliance on forward-looking statements; AEye assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. AEye gives no assurance that AEye will achieve any of its expectations.

AEYE, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
 

September 30,

2022

 

December 31,

2021

      
ASSETS     
Current Assets:     
Cash and cash equivalents$

58,490

 

 $

14,183

 

Marketable securities 

53,699

 

  

149,824

 

Accounts receivable, net 

624

 

  

4,222

 

Inventories, net 

4,024

 

  

4,085

 

Prepaid and other current assets 

5,496

 

  

5,051

 

Total current assets 

122,333

 

  

177,365

 

Right-of-use assets 

15,847

 

  

 

Property and equipment, net 

7,621

 

  

5,129

 

Restricted cash 

2,150

 

  

2,150

 

Other noncurrent assets 

2,739

 

  

1,509

 

Total assets$

150,690

 

 $

186,153

 

      
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)     
Current Liabilities:     
Accounts payable$

1,175

 

 $

2,542

 

Accrued expenses and other current liabilities 

9,888

 

  

8,739

 

Contract liabilities 

1,518

 

  

2,287

 

Convertible notes 

9,512

 

  

 

Total current liabilities 

22,093

 

  

13,568

 

Operating lease liabilities, noncurrent 

17,058

 

  

 

Deferred rent, noncurrent 

 

  

3,032

 

Other noncurrent liabilities 

518

 

  

786

 

Total liabilities 

39,669

 

  

17,386

 

Stockholders’ Equity (Deficit):     
Preferred stock 

 

  

 

Common stock 

16

 

  

16

 

Additional paid-in capital 

339,408

 

  

320,937

 

Accumulated other comprehensive loss 

(1,636

)

  

(391

)

Accumulated deficit 

(226,767

)

  

(151,795

)

Total stockholders’ equity (deficit) 

111,021

 

  

168,767

 

Total liabilities and stockholders’ equity (deficit)$

150,690

 

 $

186,153

 

      
AEYE, INC.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share data)
(Unaudited)
 
 

Three months ended September 30,

 

Nine months ended September 30,

 

2022

 

2021

 

2022

 

2021

            
Revenue:           
Prototype sales$

652

 

 $

127

 

 $

1,182

 

 $

588

 

Development contracts 

115

 

  

 

  

1,373

 

  

615

 

Total revenues 

767

 

  

127

 

  

2,555

 

  

1,203

 

Cost of revenue 

2,708

 

  

466

 

  

5,617

 

  

1,537

 

Gross profit (loss) 

(1,941

)

  

(339

)

  

(3,062

)

  

(334

)

            
Operating Expenses:           
Research and development 

8,971

 

  

7,468

 

  

28,309

 

  

19,030

 

Sales and marketing 

4,466

 

  

2,991

 

  

14,405

 

  

6,489

 

General and administrative 

7,896

 

  

6,086

 

  

29,053

 

  

13,846

 

Total operating expenses 

21,333

 

  

16,545

 

  

71,767

 

  

39,365

 

Loss from operations 

(23,274

)

  

(16,884

)

  

(74,829

)

  

(39,699

)

            
Other income (expense), net:           
Change in fair value of embedded derivative liability and warrant liabilities 

16

 

  

341

 

  

125

 

  

222

 

Gain on PPP loan forgiveness 

 

  

 

  

 

  

2,297

 

Interest income and other 

335

 

  

69

 

  

1,109

 

  

74

 

Interest expense and other 

(688

)

  

(919

)

  

(1,338

)

  

(2,871

)

Total other income (expense), net 

(337

)

  

(509

)

  

(104

)

  

(278

)

Provision for income tax expense 

13

 

  

 

  

39

 

  

 

Net loss$

(23,624

)

 $

(17,393

)

 $

(74,972

)

 $

(39,977

)

            
Per Share Data           
Net loss per common share (basic and diluted)$

(0.15

)

 $

(0.15

)

 $

(0.48

)

 $

(0.39

)

Weighted average common shares outstanding (basic and diluted) 

159,312,203

 

  

114,891,595

 

  

156,702,000

 

  

102,953,263

 

            
AEYE, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
   
 

Nine Months Ended September 30,

 

2022

 

2021

      
Cash flows from operating activities:     
Net loss$

(74,972

)

 $

(39,977

)

Adjustments to reconcile net loss to net cash used in operating activities:     
Depreciation and amortization 

794

 

  

769

 

Noncash lease expense relating to operating lease right-of-use assets 

993

 

  

 

Inventory write-downs, net of scrapped inventory 

576

 

  

 

Change in fair value of embedded derivative liability and warrant liabilities 

(125

)

  

(222

)

Noncash gain on PPP loan forgiveness 

 

  

(2,297

)

Stock-based compensation 

18,003

 

  

6,522

 

Amortization of debt issuance costs 

 

  

725

 

Amortization of debt discount 

 

  

752

 

Realized loss on redemption of marketable securities 

77

 

  

 

Amortization of premiums on marketable securities, net of change in accrued interest 

1,211

 

  

47

 

Other 

 

  

286

 

Changes in operating assets and liabilities:     
Accounts receivable, net 

3,598

 

  

9

 

Inventories, current and noncurrent, net 

(2,256

)

  

(2,197

)

Prepaid and other current assets 

(445

)

  

(5,305

)

Other noncurrent assets 

420

 

  

(142

)

Accounts payable 

(1,236

)

  

840

 

Accrued expenses and other current liabilities 

220

 

  

1,417

 

Operating lease liabilities 

(983

)

  

 

Deferred rent 

 

  

(400

)

Contract liabilities 

(1,400

)

  

(415

)

Net cash used in operating activities 

(55,525

)

  

(39,588

)

Cash flows from investing activities:     
Purchase of property and equipment 

(3,402

)

  

(713

)

Proceeds from redemptions and maturities of marketable securities 

93,592

 

  

 

Purchase of available-for-sale securities 

 

  

(129,999

)

Net cash provided by (used in) operating activities 

90,190

 

  

(130,712

)

Cash flows from financing activities:     
Proceeds from exercise of stock options 

1,032

 

  

100

 

Proceeds from Business Combination and PIPE financing 

 

  

256,811

 

Transaction costs related to Business Combination and PIPE financing 

 

  

(50,985

)

Proceeds from the issuance of convertible notes 

10,000

 

  

8,045

 

Proceeds from bank loan 

 

  

10,000

 

Principal payments on bank loans 

 

  

(13,333

)

Payment of debt issuance costs 

 

  

(717

)

Taxes paid related to the net share settlement of equity awards 

(4,252

)

  

 

Repurchase of stock options 

 

  

(1,500

)

Proceeds from issuance of common stock under the Common Stock Purchase Agreement 

2,891

 

  

 

Stock issuance costs related to the Common Stock Purchase Agreement 

(29

)

  

 

Net cash provided by financing activities 

9,642

 

  

208,421

 

Net increase in cash, cash equivalents and restricted cash 

44,307

 

  

38,121

 

Cash, cash equivalents and restricted cash at beginning of period 

16,333

 

  

16,497

 

Cash, cash equivalents and restricted cash at end of period

$

60,640

 

 

$

54,618

 

      
AEYE, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except share and per share data)
(Unaudited)
 
 

Three months ended September 30,

 

Nine months ended September 30,

 

2022

 

2021

 

2022

 

2021

GAAP net loss$

(23,624

)

 $

(17,393

)

 $

(74,972

)

 $

(39,977

)

Non-GAAP adjustments:           
Stock-based compensation 

6,106

 

  

2,292

 

  

18,003

 

  

6,522

 

Expenses related to registration statement on Form S-1/S-3s 

54

 

  

1,773

 

  

304

 

  

2,198

 

Change in fair value of embedded derivative and warrant liabilities 

(16

)

  

(341

)

  

(125

)

  

(222

)

Stock issuance costs 

 

  

 

  

28

 

  

 

Debt issuance costs 

437

 

  

 

  

437

 

  

 

Gain on PPP Loan Forgiveness 

 

  

 

  

 

  

(2,297

)

Non-GAAP net loss$

(17,043

)

 $

(13,669

)

 $

(56,325

)

 $

(33,776

)

Depreciation and amortization expense 

331

 

  

271

 

  

794

 

  

769

 

Interest income and other 

(335

)

  

(69

)

  

(1,109

)

  

(74

)

Interest expense and other 

307

 

  

919

 

  

928

 

  

2,871

 

Provision for income tax expense 

13

 

  

 

  

39

 

  

 

Adjusted EBITDA$

(16,727

)

 $

(12,548

)

 $

(55,673

)

 $

(30,210

)

            
GAAP net loss per share attributable to common stockholders:           
Basic and diluted$

(0.15

)

 $

(0.15

)

 $

(0.48

)

 $

(0.39

)

Non-GAAP net loss per share attributable to common stockholders:           
Basic and diluted$

(0.11

)

 $

(0.12

)

 $

(0.36

)

 $

(0.33

)

Shares used in computing GAAP net loss per share attributable to common stockholders:           
Basic and diluted 

159,312,203

 

  

114,891,595

 

  

156,702,000

 

  

102,953,263

 

Shares used in computing Non-GAAP net loss per share attributable to common stockholders:           
Basic and diluted 

159,312,203

 

  

114,891,595

 

  

156,702,000

 

  

102,953,263

 

 

Sign Up To Get Daily Green Stock News In Your Inbox

Please review our Disclaimer and Privacy Policy before subscribing.

STOCK QUOTE

FEATURED GREEN STOCK

Sienna Resources

Sienna Resources is at the forefront of the battery metals revolution. The company is one of the largest landholders in the prolific Clayton Valley district, which is the only lithium producing region in the United States and located just miles...

CLICK TO LEARN MORE

FEATURED GREEN STOCK

Else Nutrition

Else Nutrition is changing the face of early childhood nutrition with clean, sustainable, plant-based products. The company has developed the world’s first whole plant-based infant formula that is targeting the $100+ billion global...

CLICK TO LEARN MORE

COPYRIGHT ©2022 GREEN STOCK NEWS